John Russell has been appointed president, chief executive officer and member of the Cardiva Board of Directors. Russell succeeds Charles Maroney, who has served as chief executive officer since June, 2010 and who will remain in his role as member of the Cardiva board of directors.
“As Cardiva prepares to enter the next phase of sales growth, we sought a leader who had direct commercial and market development experience, who could help the company achieve its sales and profitability goals,” said Maroney. “John is an outstanding choice to lead the company into this next phase of growth.”
Russell has over 30 years of experience in the medical device field including sales, marketing, business development and research and development. He was most recently chief executive officer of Corventis, a venture capital financed medical device company that was acquired by Medtronic in 2014. Immediately prior to Corventis, Russell was head of US Sales for the cardiac rhythm management division of Boston Scientific.
Russell said, “Cardiva has an excellent opportunity to transform the vascular closure market and make a real difference for the millions of patients undergoing cardiac and peripheral vascular procedures.”